Description
The FDA-approved drug bexarotene has been predominantly utilized for the treatment of cutaneous T-cell lymphoma (CTLC), but has shown promise as an off label treatment for various other cancers as well as Alzheimer's disease (AD).
Copyright Statement
Download count: 0
Details
Contributors
- Davidson, Jesse Raymond (Author)
- Wagner, Carl (Thesis director)
- Ball, Rebecca (Committee member)
- School of Mathematical and Natural Sciences (Contributor)
- Barrett, The Honors College (Contributor)
Date Created
The date the item was original created (prior to any relationship with the ASU Digital Repositories.)
2016-05
Subjects
Resource Type
Collections this item is in